All the information you need about ALIZE PHARMA III to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-01 | Public | 2021-12-31 | Complete |
| 2021-07-20 | Public | 2020-12-31 | Complete |
| 2020-06-08 | Public | 2019-12-31 | Complete |
| 2019-05-17 | Public | 2018-12-31 | Complete |
| 2018-06-25 | Public | 2017-12-31 | Complete |
| 2017-05-16 | Public | 2016-12-31 | Complete |
| Name | ALIZE PHARMA III |
| Siren | 803919729 |
| Closing | 2016-12-31 |
| Registry code | 6901 |
| Registration number | B2017/014153 |
| Management number | 2014B04522 |
| Activity code | 7219Z |
| Closing date n-1 | 2015-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 18 |
| Filing date | 2017-05-16 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 69130 ECULLY |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BX Customers and related accounts | ||||
CD Marketable securities | 400 000.00 | 400 000.00 | 400 000.00 | |
CF Cash and cash equivalents | 259 563.00 | 259 563.00 | 259 563.00 | |
CH Prepaid expenses | 56 825.00 | 56 825.00 | 56 825.00 | |
CJ TOTAL (II) | 849 294.00 | 849 294.00 | 849 294.00 | |
CO Grand total (0 to V) | 849 294.00 | 849 294.00 | 849 294.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
226 Operating subsidies received | 30 000.00 | |||
230 Other income | 2.00 | 2.00 | 2.00 | |
232 Total operating income excluding VAT | 4 018.00 | 78 175.00 | 4 018.00 | |
242 Other external expenses | 1 054 563.00 | 1 032 831.00 | 1 054 563.00 | |
244 Taxes, duties and similar payments | 888.00 | 2 423.00 | 888.00 | |
262 Other expenses | 3.00 | 131.00 | 3.00 | |
270 Operating profit | -1 051 436.00 | -957 210.00 | -1 051 436.00 | |
280 Financial income | 11 445.00 | 13 757.00 | 11 445.00 | |
294 Financial expenses | 35 895.00 | 34 080.00 | 35 895.00 | |
306 Income tax's | -105 426.00 | -186 847.00 | -105 426.00 | |
310 Profit or loss | -970 460.00 | -790 685.00 | -970 460.00 | |
DA Share or individual capital | 51 218.00 | 51 218.00 | 51 218.00 | |
DB Share, merger, contribution premiums, etc. | 1 756 606.00 | 1 756 606.00 | 1 756 606.00 | |
DH Retained earnings | -790 685.00 | -790 685.00 | ||
DI RESULTS FOR THE YEAR (Profit or Loss) | -970 460.00 | -790 685.00 | -970 460.00 | |
DL TOTAL (I) | 46 679.00 | 1 017 139.00 | 46 679.00 | |
DN Conditional advances | 450 000.00 | 450 000.00 | ||
DO TOTAL (II) | 450 000.00 | 450 000.00 | ||
DU Loans and Debts from Credit Institutions (3) | 300 237.00 | 300 090.00 | 300 237.00 | |
DX Trade payables and related accounts | 51 047.00 | 166 824.00 | 51 047.00 | |
DY Tax and social security liabilities | 1 331.00 | 8 390.00 | 1 331.00 | |
EC TOTAL (IV) | 352 615.00 | 475 304.00 | 352 615.00 | |
EE Grand total (I to V) | 849 294.00 | 1 492 443.00 | 849 294.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 51 047.00 | 51 047.00 | 51 047.00 | |
VG Loans with a maturity of up to one year at origin | 237.00 | 237.00 | 237.00 | |
VH Loans with a maturity of more than one year at origin | 300 000.00 | 180 000.00 | 300 000.00 | |
VS Prepaid expenses | 56 825.00 | 56 825.00 | ||
VT TOTAL – STATEMENT OF RECEIVABLES | 189 731.00 | 189 731.00 | 189 731.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 352 615.00 | 52 615.00 | 180 000.00 | 352 615.00 |
